ISIN | LU0328683049 |
---|---|
Valor Number | 3505661 |
Bloomberg Global ID | BBG000H85187 |
Fund Name | Europe Index -IS EUR |
Fund Provider |
Pictet Asset Management S.A.
Genève, Switzerland Phone: +41 58 323 10 24 www.assetmanagement.pictet |
Fund Provider | Pictet Asset Management S.A. |
Representative in Switzerland |
Pictet Asset Management S.A. Genève 73 Phone: +41 58 323 30 00 |
Distributor(s) |
Credit Suisse AG Zürich Phone: +41 44 333 11 11 UBS AG Zürich Phone: +41 44 234 11 11 Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | To achieve a performance comparable to the reference index. The Fund aims for the full physical replication of the MSCI Europe Index (the “Benchmark Index”). |
Peculiarities |
Current Price * | 279.08 EUR | 09.04.2025 |
---|---|---|
Previous Price * | 288.83 EUR | 08.04.2025 |
52 Week High * | 333.38 EUR | 03.03.2025 |
52 Week Low * | 279.08 EUR | 09.04.2025 |
NAV * | 279.08 EUR | 09.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,031,525,162 | |
Unit/Share Assets *** | 33,511,401 | |
Trading Information SIX |
YTD Performance | -6.49% |
31.12.2024 - 09.04.2025
31.12.2024 09.04.2025 |
---|---|---|
YTD Performance (in CHF) | -6.61% |
31.12.2024 - 09.04.2025
31.12.2024 09.04.2025 |
1 month | -13.33% |
10.03.2025 - 09.04.2025
10.03.2025 09.04.2025 |
3 months | -8.34% |
09.01.2025 - 09.04.2025
09.01.2025 09.04.2025 |
6 months | -8.56% |
09.10.2024 - 09.04.2025
09.10.2024 09.04.2025 |
1 year | -4.23% |
09.04.2024 - 09.04.2025
09.04.2024 09.04.2025 |
2 years | +7.35% |
11.04.2023 - 09.04.2025
11.04.2023 09.04.2025 |
3 years | +11.71% |
11.04.2022 - 09.04.2025
11.04.2022 09.04.2025 |
5 years | +61.09% |
09.04.2020 - 09.04.2025
09.04.2020 09.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 10.6611 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 09.04.2025 |
Novo Nordisk AS Class B | 2.51% | |
---|---|---|
SAP SE | 2.50% | |
ASML Holding NV | 2.42% | |
Nestle SA | 2.20% | |
AstraZeneca PLC | 2.03% | |
Roche Holding AG | 2.02% | |
Novartis AG Registered Shares | 1.85% | |
HSBC Holdings PLC | 1.84% | |
Shell PLC | 1.77% | |
Lvmh Moet Hennessy Louis Vuitton SE | 1.72% | |
Last data update | 28.02.2025 |
TER *** | 0.30% |
---|---|
TER date *** | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.30% |
Ongoing Charges *** | 0.31% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |